The Advantages of the eRapid Nebulizer System
This entry was posted on March 14, 2019.
More than 70,000 people worldwide are living with cystic fibrosis and more than 1,000 new cases are diagnosed each year. The eRapid nebulizer system by PARI Respiratory is designed to help with the management of breathing treatments for cystic fibrosis patients. The eRapid system is an exceptional and advanced device that can significantly reduce treatment times and optimize the amount of available medicine to the lungs.
Small, lightweight, and with multiple power options, the eRapid incorporates the patented PARI eFlow® technology—a vibrating perforated membrane system that ensures precise particle size with extraordinarily fast treatment times. Treatment can be reduced from 6 to 8 minutes to just 2 to 3 minutes.
The eRapid Nebulizer Handset was designed to be used with Pulmozyme, which thins out the mucus in cystic fibrosis patients. This unique delivery system is designed to allow more of the medication to reach deeply into the lungs while delivering a much faster treatment, making patients more compliant with physician orders. The handset can be disinfected by boiling in distilled water.